scispace - formally typeset
G

Gary Gilliland

Researcher at Brigham and Women's Hospital

Publications -  15
Citations -  2545

Gary Gilliland is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Leukemia & Haematopoiesis. The author has an hindex of 9, co-authored 15 publications receiving 2491 citations. Previous affiliations of Gary Gilliland include Howard Hughes Medical Institute.

Papers
More filters
Journal ArticleDOI

Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction

TL;DR: An adaptation of the polymerase chain reaction (PCR) for highly accurate quantitation of mRNA or DNA from a small number of cells for expression of two cytokines and the copy number of the human GM-CSF gene in normal human cells is described.
Journal ArticleDOI

MOZ-TIF2, but Not BCR-ABL, Confers Properties of Leukemic Stem Cells to Committed Murine Hematopoietic Progenitors.

TL;DR: In this article, the authors tested the ability of representative leukemia oncogenes to transform committed myeloid progenitor cells that lack the capacity for self-renewal, and showed that an active MOZ-TIF2, but not BCR-ABL, can collaborate with mutations induced by retroviral mutagenesis to confer properties of leukemic stem cells to committed progenitors.
Journal ArticleDOI

Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells

TL;DR: The proapoptotic IAP inhibitor, LBW242, was shown in proliferation studies done in vitro to enhance the killing of PKC412-sensitive and PKC 412-resistant cell lines expressing mutant FLT3 when combined with either PKC512 or standard cytotoxic agents (doxorubicin and Ara-c).